….please send $5 or $50 or $500 or $5000, what ever you think the Wiley Protocol has been worth to you to UTT for the Study…”

The University of Texas at Tyler is launching a study of bio-identical hormones, including the Wiley Protocol®.  The study, called Bioidentical Hormones On Trial, or B.H.O.T., will make a comparison of patterns of administration and dosing of compounded bio-identical hormone therapy (BHT). This study will be the first of its kind to track and quantify outcomes based on dosing and patterns of administration of BHT. The principal objective of the study will be to examine clinical outcomes and quality of life indicators of patients receiving BHT at 10 to 12 primary care providers’ practices.

Currently an accepted standard for compounded bio-identical hormone replacement protocols or therapy does not exist. The results of the study will be used to help establish which dosage and pattern of BHT administration is most effective. Results will be used to design a prospective, randomized clinical trial with the goal of standardizing BHT dosing and administration patterns.  The principal investigator for the study is Assistant Professor Janith Williams, DNP, WHNP, RNC, and the co principal investigator is Julie Taguchi, MD, physician and research coordinator at Sansum Clinic Santa Barbara, California.
The research study is accepting donations which can be sent to: Office of Women's Health Research Bio-identical Hormone Research Project, c/o Dr. Janith Williams, College of Nursing and Health Sciences, The University of Texas at Tyler, Tyler, Texas, 75799. One hundred percent of the funds received will be applied to this project. Donations of any size are welcome and donors will receive a receipt for tax purposes and a letter recognizing contributions.